Acutaas Chemicals Limited (NSE:ACUTAAS)

India flag India · Delayed Price · Currency is INR
1,707.60
-1.60 (-0.09%)
At close: Dec 5, 2025
51.17%
Market Cap 139.80B
Revenue (ttm) 10.97B
Net Income (ttm) 2.24B
Shares Out 81.87M
EPS (ttm) 27.38
PE Ratio 62.37
Forward PE 45.46
Dividend 1.50 (0.09%)
Ex-Dividend Date Sep 18, 2025
Volume 112,949
Average Volume 325,601
Open 1,715.40
Previous Close 1,709.20
Day's Range 1,688.00 - 1,730.00
52-Week Range 918.78 - 1,902.00
Beta -0.02
RSI 47.97
Earnings Date Feb 14, 2026

About Acutaas Chemicals

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist... [Read more]

Sector Materials
Founded 2004
Employees 879
Stock Exchange National Stock Exchange of India
Ticker Symbol ACUTAAS
Full Company Profile

Financial Performance

In 2024, Acutaas Chemicals's revenue was 10.07 billion, an increase of 40.34% compared to the previous year's 7.17 billion. Earnings were 1.59 billion, an increase of 271.06%.

Financial Statements

News

There is no news available yet.